| [1] |
Brown CJ, Gallinger S, Church J, et al. Long-term effects of aspirin on colorectal cancer[J]. J Am Coll Surg, 2012, 214(6): 1023-6.
|
| [2] |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
|
| [3] |
Sakoguchi-Okada N, Takahashi-Yanaga F, Fukada K, et al. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells [J]. Biochem Pharmacol, 2007, 73(9): 1318-29.
|
| [4] |
Uddin S, Ahmed M, Hussain A, et al. Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer[J]. Int J Cancer, 2010, 126(2): 382-94.
|
| [5] |
Xiang S, Sun Z, He Q, et al. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells[J]. Med Oncol, 2010, 27(2): 37 9-87.
|
| [6] |
Hossain MA, Kim DH, Jang JY, et al. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo[J]．Int J Oncol, 2012, 40(5): 1636-42.
|
| [7] |
Coghill AE, Newcomb PA, Campbell PT, et al. Prediagnostic nonsteroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer[J]. Gut, 2011, 60(4): 491-8.
|
| [8] |
Tárraga López PJ, Albero JS, Rodríguez-Montes JA. Primary and secondary prevention of colorectal cancer[J]. Clin Med Insights Gastroenterol, 2014, 7: 33-46.
|
| [9] |
Zuo XN, Ding JH, Zou GH. Clinical observation of Capox regimen combined with aspirin in the treatment of elderly patients with metastatic colon cancer[J]. Zhonghua Lin Chuang Yi Shi Za Zhi(Dian Zi Ban), 2013, 7(6): 74-6. [左新年, 丁江华, 邹国辉. Capox方案联合阿司匹林治疗老年转移性结肠癌的临床观察 [J] 中华临床医师杂志(电子版), 2013, 7(6): 74-6.]
|
| [10] |
Qian J, Chen WS, Wen KN, et al. Expression of Slug and E-cadherin in colorectal carcinoma and its clinical significance[J]. Zhongguo Lao Nian Xue Za Zhi, 2012, 32(13): 2683-5. [钱江, 陈 旺盛, 文坤明, 等. Slug 和E-cadherin在结直肠癌组织中的表达 及临床意义[J]. 中国老年学杂志, 2012, 32(13): 2683-5.]
|
| [11] |
Be?ta? R, Kaplan MA, I?ikdo?an A. The correlation between serum VEGF levels and known prognostic risk factors in colorect alcarcinoma[J]. Hepatogastroenterology, 2014, 61(130): 267-71.
|
| [12] |
Wang Y, Yao X, Ge J, et al. Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? a systematic review and meta-analysis[J]. Scientific World J, 2014, 2014: 102736.
|
| [13] |
Xu Y. The expression of VEGF-C, VEGF-D and VEGFR-3 in colorectal carcinoma and its clinical significance[J]. Zhongguo Lao Nian Xue Za Zhi, 2013, 33(18): 4432-3. [徐阳. VEGF-C, VEGF-D和VEGFR-3在结直肠癌组织中的表达及临床意义[J]. 中国老年学杂志, 2013, 33(18): 4432-3.]
|
| [14] |
Li LH, Liu H, Jiang MW, et al. The relationship between the expression of VEGF-C and CK20 of mRNA and lymph node in the peripheral blood of patients with colon cancer[J]. Wei Chang Bing Xue He Gan Bing Xue Za Zhi, 2012, 21(2): 126-8. [李林海, 刘辉, 江明万, 等. 结肠癌患者外周血VEGF-C和CK20 mRNA 的表达与淋巴转移的关系[J]. 胃肠病学和肝病学杂志, 2012, 21 (2): 126-8.]
|
| [15] |
Etulain J, Fondevila C, Negrotto S, et al. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin[J]. Br J Pharmacol, 2013, 170(2): 255-65.
|
| [16] |
Ouyang N, Williams JL, Rigas B, et al. NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts[J]. Carcinogenesis, 2008, 29 (9): 1794-8.
|
| [17] |
MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Dev Cell, 2009, 17(1): 9-26.
|
| [18] |
Liu F, Millar SE. Wnt/beta-catenin signaling in oral tissue development and disease[J]. J Dent Res, 2010, 89(4): 318-30.
|
| [19] |
Liu J, Ou YR, Jin GY, et al. Expression of β-catenin and E-cadherin in colorectal carcinoma and its clinical significance[J]. Zhongguo Zu Zhi Hua Xue Yu Xi Bao Hua Xue Za Zhi, 2013, 22 (3): 234-9. [刘娟, 欧玉荣, 景桂英, 等. β-catenin和E-cadherin在结直肠癌中 的表达及其临床意义[J]. 中国组织化学与细胞化学杂志, 2013, 22 (3): 234-9.]
|
| [20] |
Gomez-Millan J, Perez L, Aroca I, et al. Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: prognostic significance[J]. BMC Cancer, 2014, 14: 192.
|
| [21] |
Sebio A, Kahn M, Lenz H. The potential of targeting Wnt/ β-catenin in colon cancer[J]. Expert Opin Ther Targets, 2014, 18 (6): 611-5.
|
| [22] |
Herbst A, Jurinovic V, Krebs S, et al. Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling[J]. BMC Genomics, 2014,15:74.
|
| [23] |
Yang Y, Xu W, Peng K, et al. Amentoflavone induces apoptosis in SW480 human colorectal cancer cells via regulating β-catenin and caspase-3 expressions[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2014, 34 (7): 1035-8. [杨雨, 徐文娟, 彭康, 等. 穗花杉双黄酮通过影响 caspase-3和β-catenin表达诱导结肠癌细胞SW480凋亡[J]. 南方 医科大学学报, 2014, 34(7): 1035-8.]
|
| [24] |
Hwang I, Kim J, Jeong S. β-Catenin and peroxisome proliferatoractivated receptor-δ coordinate dynamic chromatin loops for the transcription of vascular endothelial growth factor A gene in colon cancer cells[J]. J Biol Chem, 2012, 287(49): 41364-73.
|
| [25] |
Easwaran V, Lee SH, Inge L, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer [J]. Cancer Res, 2003, 63(12): 3145-53.
|
| [26] |
Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor bythe Wnt and K-ras pathways in colcnic neoplasia[J]. Cancer Res, 2001, 61(16): 6050-4.
|
下载:
